849 related articles for article (PubMed ID: 15634724)
1. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
2. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
[TBL] [Abstract][Full Text] [Related]
3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.
Reiter EO; Price DA; Wilton P; Albertsson-Wikland K; Ranke MB
J Clin Endocrinol Metab; 2006 Jun; 91(6):2047-54. PubMed ID: 16537676
[TBL] [Abstract][Full Text] [Related]
5. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
Darendeliler F; Lindberg A; Wilton P
Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
[TBL] [Abstract][Full Text] [Related]
6. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
Reinehr T; Bechtold-Dalla Pozza S; Bettendorf M; Doerr HG; Gohlke B; Hauffa BP; Kaspers S; Land C; Mehls O; Schwab KO; Stahnke N; Ranke MB;
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):544-8. PubMed ID: 22006181
[TBL] [Abstract][Full Text] [Related]
7. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
Geffner M; Lundberg M; Koltowska-Häggström M; Abs R; Verhelst J; Erfurth EM; Kendall-Taylor P; Price DA; Jonsson P; Bakker B
J Clin Endocrinol Metab; 2004 Nov; 89(11):5435-40. PubMed ID: 15531494
[TBL] [Abstract][Full Text] [Related]
8. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
9. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
10. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
[TBL] [Abstract][Full Text] [Related]
12. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
13. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
14. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
Darendeliler F; Berberoğlu M; Ocal G; Adiyaman P; Bundak R; Günöz H; Baş F; Darcan S; Gökşen D; Arslanoğlu I; Yildiz M; Ercan O; Ercan G; Ozerkan E; Can S; Böber E; Adal E; Sarikaya S; Dallar Y; Siklar Z; Bircan I; Bideci A; Yüksel B; Büyükgebiz A
J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
[TBL] [Abstract][Full Text] [Related]
15. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
Ranke MB; Lindberg A;
J Clin Endocrinol Metab; 2010 Mar; 95(3):1229-37. PubMed ID: 20097713
[TBL] [Abstract][Full Text] [Related]
16. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
[TBL] [Abstract][Full Text] [Related]
17. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).
Ranke MB; Lindberg A; Cowell CT; Wikland KA; Reiter EO; Wilton P; Price DA;
J Clin Endocrinol Metab; 2003 Jan; 88(1):125-31. PubMed ID: 12519840
[TBL] [Abstract][Full Text] [Related]
18. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
[TBL] [Abstract][Full Text] [Related]
19. Prediction of adult height in growth-hormone-treated children with growth hormone deficiency.
de Ridder MA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Mar; 92(3):925-31. PubMed ID: 17179199
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
